COPSAC COPSAC COPSAC COPSAC
  • About COPSAC
    • About
    • Organization Diagram
    • Board of Directors
    • Research team
    • Location
    • Funding
    • Logo
    • Open positions
  • COPSAC cohorts
    • COPSAC2000 cohort
    • COPSAC2010 cohort
    • COPSACSEVERE cohort
    • COPSACACUTE cohort
    • Methods
    • Data overview
      • COPSAC2000 Clinic
      • COPSAC2000 Exposures
      • COPSAC2000 Omics
      • COPSAC2000 Biobank
      • COPSAC2010 Clinic
      • COPSAC2010 Exposures
      • COPSAC2010 Omics
      • COPSAC2010 Biobank
  • Dissemination
    • Theses
    • Literature for parents
  • Research Projects
    • RestoreGut
    • COPSYCH Research Alliance
    • HEDIMED Consortium
    • EDIAQI Consortium
    • EAGLE Consortium
    • EarlyVir
  • Strategy
  • ‌

Telegiz: Fish Oil During Pregnancy Cuts Down Asthma Risk in Babies

    Home News Telegiz: Fish Oil During Pregnancy Cuts Down Asthma Risk in Babies
    NextPrevious

    Telegiz: Fish Oil During Pregnancy Cuts Down Asthma Risk in Babies

    By Dansk Børne Astma Center | News, PUFA | Comments are Closed | 2 January, 2017 |

    By Dane Lorica

    Blood samples were taken before and after consumption of supplements. According to the results, women who received low levels of fish oil’s primary ingredients, docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), lowered their children’s rate of wheezing and asthma to 17.5 from 34.1 percent. However, it was observed that allergies from egg products, milk, and severe asthma cannot be reduced by fish oil intake.

    Dr. Hans Bisgaard advised that besides taking supplements, women should “really need to be very fond of fish to get sufficient amounts” of fish oil benefits in their diet.

    Statistics revealed that one in every five children suffer from asthma and respiratory conditions such as wheezing.

    The researchers have recommended that the study is conducted in other countries where consumption of fish oil is low.

    Dr. Christopher Ramsden said, “future work is also needed to determine whether lower doses are effective and whether these results can be replicated in other populations.” Dr. Ramsden added that “before these findings can be applied to clinical practice, it is, therefore, imperative to ensure that this dose had no adverse effects on behavior, cognition or other long-term outcomes.”

    Read more

    No tags.
    NextPrevious

    CONTACT

    COPSAC
    Copenhagen Prospective Studies on Asthma in Childhood
    Copenhagen University Hospital, Herlev-Gentofte
    phone +45 3867 7360
    contact@copsac.com
    COPSAC • Copenhagen University Hospital, Herlev-Gentofte • Denmark © 2023
    • About COPSAC
      • About
      • Organization Diagram
      • Board of Directors
      • Research team
      • Location
      • Funding
      • Logo
      • Open positions
    • COPSAC cohorts
      • COPSAC2000 cohort
      • COPSAC2010 cohort
      • COPSACSEVERE cohort
      • COPSACACUTE cohort
      • Methods
      • Data overview
        • COPSAC2000 Clinic
        • COPSAC2000 Exposures
        • COPSAC2000 Omics
        • COPSAC2000 Biobank
        • COPSAC2010 Clinic
        • COPSAC2010 Exposures
        • COPSAC2010 Omics
        • COPSAC2010 Biobank
    • Dissemination
      • Theses
      • Literature for parents
    • Research Projects
      • RestoreGut
      • COPSYCH Research Alliance
      • HEDIMED Consortium
      • EDIAQI Consortium
      • EAGLE Consortium
      • EarlyVir
    • Strategy
    • ‌
    COPSAC